Yelak Biru is a multiple myeloma patient, turned myeloma research advocate. He was diagnosed at the age of 25 years with stage III myeloma. Working with a team of medical practitioners and educating himself through active support group leadership, online information and advocacy sites, social media and resources from the International Myeloma Foundation, Yelak has been able to successfully integrate myeloma into his life for more than two decades. Yelak believes that through research advocacy, patients will be able to better balance quality of life with treatment outcomes while helping accelerate both translational and basic myeloma research. Through his active participation in the Global Myeloma Action Network and facilitation of the SmartPatients.com myeloma group, Yelak understands the need and is passionate about improving access to life saving cancer drugs globally and advancing the innovation pipeline through research and patient participation. To that effect, Yelak is a member of ECOG Patient Advocate and Myeloma Committee as well as a voting member of the NCI Myeloma Steering Committee. Yelak is a member of the International Myeloma Foundation board of directors, active on Twitter under the handle @NorthTxMsg and works as an Information Technology Director for a fortune 50 global company.
You can see my upcoming and previous webinars here.